Skip to content

Assessment of One-shot Cardiac-cervical-intracranial MRI in the Etiological Work up of Ischemic Stroke and Transient Ischemic Attacks

Assessment of One-shot Cardiac-cervical-intracranial MRI in the Etiological Work up of Ischemic Stroke and Transient Ischemic Attacks

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04790357
Acronym
Concise
Enrollment
244
Registered
2021-03-10
Start date
2021-04-01
Completion date
2023-05-01
Last updated
2021-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke, Transient Ischemic Attack

Brief summary

Stroke is a major public health issue in developed countries. A full etiological work up within a short time is critical to implement the appropriate preventive treatment. The etiological work up is actually based on a clinical examination and on a group of paraclinical examinations. The realization of the standard strategy is time consuming, and increase the cost of the medical care. A non-invasive one-shot examination of the heart, the aorta and the cervical and intracranial arteries (cci-MRI) could overcome these disadvantages.The investigator therefore propose to carry out an overall assessment of the performance of the cci-MR in the etiological work up of ischemic strokes and TIAs compared to the reference strategy

Interventions

OTHERCurrent guidelines

doppler ultrasound and/or angio CT-scan of the cervical arteries, angio CT-scan of the intracranial arteries, TTE wich can be supplemented by a TEE at the discretion of the investigator. The TEE is not mandatory

OTHERcc-MRI

of one-shot cardiac-cervical-intracranial MRI: cardiac MRI with late-enhancement, angio-MRI of the cervical and intracranial arteries

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* • Man or woman aged from 18 to 85 years old, * Patients victims of an ischemic stroke or a TIA in the 2 days before inclusion, Symptoms thought to be consistent with TIA were those defined by the ad hoc Committee established by the Advisory Council for the National Institute of Neurological and Communicative Disorders and Stroke65 * Rankin score: mRS ≤3 * Patient having given their free written and informed consent, or preliminary oral informed consent attested by a third party followed by signed informed consent as soon as possible, * Affiliated to a social security scheme or equivalent, * That are not the subject of any legal protection measures

Exclusion criteria

* •TIA symptoms limited to isolated numbness, * changes, or isolated dizziness/vertigo * Agitation, severe swallowing * Contraindication to an MRI and the injection of gadolinium, * Known history of hypersensitivity to the MRI contrast product, * Risk of pregnancy or known pregnancy revealed when questioned, Breastfeeding, * Patient unable to understand or poorly understanding French.

Design outcomes

Primary

MeasureTime frameDescription
To evaluate the consistency between the reference strategy and the cci-MR strategy for etiological work up according to the ASCOD classification, in ischemic stroke and TIA patientsWithin 8 days after hospitalizationThe primary endpoint will be based on the consistency for each patient of the etiological work up according to the ASCOD classification evaluated with cci-MR in comparison of the reference strategy

Secondary

MeasureTime frameDescription
To evaluate the agreement between cci-MR and the reference method for each etiological subgroup: in the context of ischemic stroke or TIA.Within 8 days after hospitalizationAgreement for each etiological subgroup between cci-MR and the reference method.
To assess the improvement of the detection of myocardial scar with cci-MR compared to reference strategyWithin 8 days after hospitalizationPresence or absence of ischemic myocardial scar
To assess the atherosclerotic burden (coronary, intracranial, cervical, aortic) assessed with cci-MR compared to the reference strategy,Within 8 days after hospitalizationPresence or absence of coronary, intracranial, cervical, aortic atheroma. The diagnostic work up will focus on cervical artery stenosis ≥ 50%; aortic arch atheroma ≥ 4 mm; intracranial artery stenosis ≥ 50% and presence of ischemic myocardial scar. The scar pattern was classified as ischemic if its distribution was sub-endocardial to transmural within a coronary vascular territory and if scar was associated with segmental systolic dysfunction on corresponding cine images. Atherosclerotic burden will be classified in 0, 1, 2, 3 and 4 atherosclerotic levels according to the number of arterial territories affected by at least one significant abnormality.
To assess the additional yield of cci-MR in cryptogenic patients and in those with embolic stroke of undetermined source (ESUS) with the reference strategy (ref Hart et al., Lancet Neurol. 2014:13:429-438.)Within 8 days after hospitalizationEtiology subtype according to ASCOD classification with the reference strategy + cci-MR in cryptogenic patients and in the subgroup of patients with ESUS with the reference strategy
To assess the reproducibility of the assessment of the cci-MR resultsWithin 8 days after hospitalizationThe reproducibility of the assessment of the cci-MR results will be based on the following endpoints: \- Double reading; Concordance intra and inter reviewer
To assess the rate of additional cardiologic advice recommended according to the opinion of the expert committee from data obtained with cci-MR and with the reference strategyWithin 8 days after hospitalizationPresence or absence of recommendation to have a cardiologic advice according to the opinion of the expert committee from data obtained cci-MR and with the reference strategy
To assess the preventive treatment recommended (antithrombotic drugs and specific treatments) according to the opinion of the expert committee from data obtained with cci-MR and with the reference strategyWithin 8 days after hospitalizationPresence or absence of recommendation of having antiplatelet, anticoagulant, and of having a specific care (carotid surgery, PFO closure…) according to the opinion of the expert committee from data obtained with cci-MR and with the reference strategy
To assess the feasibility of the examinations (rate of completed examinations, deadline to obtain each examination, deadline to obtain all examinations including in each strategy)Within 8 days after hospitalizationPresence or absence of full completed examinations, deadline between the date of ischemic stroke or TIA and each examination, deadline between the date of ischemic stroke or TIA and the end of all examinations including in each strategy
To assess the feeling of the patient about cci-MR and the reference strategyWithin 8 days after hospitalizationLevel of satisfaction of the patient about cci-MR and the reference strategy
To assess the rate of TEE recommended according to the opinion of the expert committee from data obtained with cci-MR and the reference strategyWithin 8 days after hospitalizationPresence or absence of recommendation to realize a TEE according to the opinion of the expert committee from data obtained with cci-MR and with the reference strategy

Countries

France

Contacts

Primary ContactMECHTOUFF Laura, MD
laura.mechtouff@chu-lyon.fr04 27 85 67 47
Backup ContactMANSUY Adeline
adeline.mansuy@chu-lyon.frO4 72 11 51 70

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026